FBIOP
Price:
$20.06
Market Cap:
$99.33M
Fortress Biotech, Inc. operates as a biopharmaceutical firm, engaged in the development and commercialization of various pharmaceutical and biotechnology offerings. Their current commercial portfolio primarily features a range of dermatology treatments. These include Ximino capsules, specifically designed for inflammatory lesions found in moderate to severe non-nodular acne vulgaris; Targadox, also used for severe acne; Exelderm cream, which addresses symptoms associated with ringworm and jock itch; Ceracade, formulated for various dry skin conditions; Luxamend, utilized for dressing and managing wounds; and Accutane capsules, prescribed for severe recalcitrant nodular acne. In its late-stag...[Read more]
Industry
Biotechnology
IPO Date
2017-11-14
Stock Exchange
NASDAQ
Ticker
FBIOP
According to Fortress Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.86. This represents a change of 20.86% compared to the average of 2.36 of the last 4 quarters.
The mean historical Current Ratio of Fortress Biotech, Inc. over the last ten years is 2.54. The current 2.86 Current Ratio has changed 11.14% with respect to the historical average. Over the past ten years (40 quarters), FBIOP's Current Ratio was at its highest in in the September 2020 quarter at 6.38. The Current Ratio was at its lowest in in the June 2023 quarter at 0.99.
Average
2.54
Median
2.24
Minimum
1.27
Maximum
5.14
Discovering the peaks and valleys of Fortress Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 96.69%
Maximum Annual Current Ratio = 5.14
Minimum Annual Increase = -79.45%
Minimum Annual Current Ratio = 1.27
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.49 | 96.69% |
| 2024 | 1.27 | -8.16% |
| 2023 | 1.38 | -23.61% |
| 2022 | 1.80 | -47.38% |
| 2021 | 3.43 | -33.32% |
| 2020 | 5.14 | 50.11% |
| 2019 | 3.43 | 71.30% |
| 2018 | 2.00 | -22.02% |
| 2017 | 2.56 | 32.30% |
| 2016 | 1.94 | -79.45% |
The current Current Ratio of Fortress Biotech, Inc. (FBIOP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.71
5-year avg
2.07
10-year avg
2.54
Fortress Biotech, Inc.’s Current Ratio is less than Equillium, Inc. (18.62), less than Coeptis Therapeutics, Inc. (3.25), less than Century Therapeutics, Inc. (10.25), less than Cue Biopharma, Inc. (3.57), less than vTv Therapeutics Inc. (14.36), greater than Senti Biosciences, Inc. (1.04), less than Genenta Science S.p.A. (14.16), greater than NRx Pharmaceuticals, Inc. (0.29), greater than Jupiter Neurosciences, Inc. (0.51), less than Telomir Pharmaceuticals, Inc. Common Stock (7.00),
| Company | Current Ratio | Market cap |
|---|---|---|
| 18.62 | $108.34M | |
| 3.25 | $57.35M | |
| 10.25 | $198.24M | |
| 3.57 | $74.79M | |
| 14.36 | $91.71M | |
| 1.04 | $24.50M | |
| 14.16 | $32.17M | |
| 0.29 | $68.62M | |
| 0.51 | $8.65M | |
| 7.00 | $48.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fortress Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fortress Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Fortress Biotech, Inc.'s Current Ratio?
How is the Current Ratio calculated for Fortress Biotech, Inc. (FBIOP)?
What is the highest Current Ratio for Fortress Biotech, Inc. (FBIOP)?
What is the 3-year average Current Ratio for Fortress Biotech, Inc. (FBIOP)?
What is the 5-year average Current Ratio for Fortress Biotech, Inc. (FBIOP)?
How does the current Current Ratio for Fortress Biotech, Inc. (FBIOP) compare to its historical average?